# \[e-drug\] MSF press release: malaria treatment (cont) **URL:** \ **Category:** e-drug\ **Created:** [February 21, 2002, 5:12am UTC](https://talk.edrugplus.org/t/e-drug-msf-press-release-malaria-treatment-cont/13719 "2002-02-21T05:12:21Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Dr\_S\_Toovey](https://avatars.discourse-cdn.com/v4/letter/d/71e660/32.png) [@Dr\_S\_Toovey](https://talk.edrugplus.org/u/Dr_S_Toovey)\ **Post date:** [February 21, 2002, 5:12am UTC](https://talk.edrugplus.org/t/e-drug-msf-press-release-malaria-treatment-cont/13719/1 "2002-02-21T05:12:21Z")
E-drug: MSF press release: malaria treatment (cont) --------------------------------------------- Recrudescence is major problem unless seven days of artemesinins is given. Compliance failure leads not only to treatment failure, but also to risk of resistance against artemesinins. If we lose the artemesinins we are in real trouble - there is nothing else coming soon to replace them. We have been using co-artemether (combined artemether-lumefantrine) in Mozambique and have had a 100% cure rate thus far. We have used it to treat uncomplicated falciparum malaria in non-immunes and semi-immunes. Monotherapy with artemesinin (or indeed any antimalarial) is now considered by many to represent unacceptable risks. I recently asked the manufacturer why a paediatric formulation was not available. It is apparently in development. The tablets can be given to children with a little condensed milk or similar to aid absorption and disguise the taste. Dr Stephen Toovey SAA-Netcare Travel Clinics American Society of Tropical Medicine and Hygiene certified in Clinical Tropical Medicine and Travellers' Health, Aviation Medical Examiner toovey@travelclinic.co.za [http://www.travelclinic.co.za](http://www.travelclinic.co.za) [http://www.malaria.co.za](http://www.malaria.co.za) P O Box 786692 Sandton 2146 South Africa Fax: +27-11-883-6152 -- To send a message to E-Drug, write to: e-drug@usa.healthnet.org To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org in the body of the message type: subscribe e-drug OR unsubscribe e-drug To contact a person, send a message to: e-drug-help@usa.healthnet.org Information and archives: [http://www.healthnet.org/programs/edrug.html](http://www.healthnet.org/programs/edrug.html)